Stock listing

Krystal Biotech, Inc.

Selected listing: K1YS34 · BMFBOVESPA · BRL · BR

Krystal Biotech, Inc. (B3:K1YS34), Health Technology. Latest release Sep 3, 2026: Krystal Biotech to Present at 2026 Cantor Global Healthcare Conference.

K1YS34:BMFBOVESPABRLBRUpdated October 2, 2026

Ticker: B3:K1YS34
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: B3
Currency: BRL

Latest news from Krystal Biotech, Inc.

Krystal Biotech to Present at 2026 Cantor Global Healthcare Conference

September 3, 2026

Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results

August 3, 2026

Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026

July 23, 2026

Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600

July 20, 2026

Krystal Biotech Announces United Kingdom MHRA Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa

May 18, 2026

All Krystal Biotech, Inc. news →

Events

Replays

Krystal Biotech, Inc. (KRYS) Q2 2026 Earnings Call
Mon, Aug 03, 2026 · 08:30 AM ET
Watch
Krystal Biotech, Inc. (KRYS) Q1 2026 Earnings Call
Mon, May 04, 2026 · 08:30 AM ET
Watch
Krystal Biotech, Inc. (KRYS) Q4 2025 Earnings Call
Tue, Feb 17, 2026 · 08:30 AM ET
Watch

Research Krystal Biotech, Inc.

Krystal Biotech, Inc. company profile

View the public company page for Krystal Biotech, Inc. on 6ix.

Krystal Biotech, Inc. news

Read company news and market updates connected to Krystal Biotech, Inc..

Krystal Biotech, Inc. investor events

Find investor webinars, events, and replay context for Krystal Biotech, Inc..